C. David Nicholson
2018
In 2018, C. David Nicholson earned a total compensation of $3.3M as Chief R&D Officer at Allergan, a 70% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,633,000 |
|---|---|
| Salary | $900,000 |
| Stock Awards | $676,926 |
| Other | $53,818 |
| Total | $3,263,744 |
Nicholson received $1.6M in non-equity incentive plan, accounting for 50% of the total pay in 2018.
Nicholson also received $900K in salary, $676.9K in stock awards and $53.8K in other compensation.
Rankings
In 2018, C. David Nicholson's compensation ranked 3,525th out of 14,244 executives tracked by ExecPay. In other words, Nicholson earned more than 75.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,525 out of 14,244 | 75th |
Division Manufacturing | 1,303 out of 5,765 | 77th |
Major group Chemicals And Allied Products | 456 out of 2,128 | 79th |
Industry group Drugs | 376 out of 1,817 | 79th |
Industry Pharmaceutical Preparations | 289 out of 1,391 | 79th |
Source: SEC filing on March 22, 2019.
Nicholson's colleagues
We found five more compensation records of executives who worked with C. David Nicholson at Allergan in 2018.